Lipotoxicity as a therapeutic target in the type 2 diabetic heart

Trang Van T Luong1, Seonbu Yang1, Jaetaek Kim1

  • 1Division of Endocrinology and Metabolism, Department of Internal Medicine, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.

Insights

Excessive lipid buildup in the heart (cardiac lipotoxicity) worsens diabetic heart disease. Targeting this condition offers a promising therapeutic strategy for managing diabetes and improving heart health.

Area of Science:

  • Cardiovascular Science
  • Metabolic Disease Research
  • Molecular Cardiology

Background:

  • Diabetic heart disease is a major complication of diabetes mellitus.
  • Cardiac lipotoxicity, excessive lipid accumulation in heart tissue, is a key driver of diabetic cardiomyopathy.
  • Mechanisms include mitochondrial dysfunction, endoplasmic reticulum stress, inflammation, and apoptosis, leading to impaired cardiac function.

Purpose of the Study:

  • To review the mechanisms of cardiac lipotoxicity in diabetes.
  • To explore therapeutic strategies targeting cardiac lipotoxicity.
  • To highlight the potential of targeting cardiac lipotoxicity for diabetes treatment.

Main Methods:

  • Literature review of recent research on cardiac lipotoxicity and diabetes.
  • Analysis of key molecular and cellular pathways involved.
  • Evaluation of current and potential therapeutic interventions.

Main Results:

  • Cardiac lipotoxicity involves mitochondrial dysfunction, ER stress, inflammation, and apoptosis.
  • These pathways contribute to impaired cardiac function in diabetic patients.
  • Therapeutic interventions targeting these mechanisms show promise.

Conclusions:

  • Targeting cardiac lipotoxicity is a viable therapeutic strategy for diabetic heart disease.
  • Further research is needed to develop effective treatments.
  • Mitigating cardiac lipotoxicity may improve cardiovascular outcomes in diabetic individuals.

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
495
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
227
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
363
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
842
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K